Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs AlyveRx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and AlyveRx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 170 · Grade C

AlyveRx

Visit AlyveRx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 69 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make AlyveRx a bad call — it's best for readers who will verify the exact formulation, full payment and refund contact before choosing an advertised starting offer. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
66
Transparency
90
72
Access Breadth
93
62
Clinical Oversight
92
71
Track Record
88
60
CoreAge RxBrief Score 94 · 69AlyveRx

Price, coverage & the tracker

CoreAge RxAlyveRx
Brief Score94/100 (A)69/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm supply and full charge

From $183/mo advertised. Vial volume alone does not establish strength, supplied weeks or payment commitment.

Full price details

Compounded semaglutide offered; complete current quote and term unknown; product advertises from $183/month; earlier listing: From $183/mo (all doses, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm current price

The product’s $283 starting display differs from a shared $329 display; obtain the selected full quote.

Full price details

Compounded tirzepatide offered; complete current quote unknown because product and shared price displays differ; earlier listing: From $249/mo (all doses, compounded)

CoverageUS only; restrictions by state, confirmed at intakeMedication-specific state and pharmacy eligibility requires confirmation
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

AlyveRx: Product cards show semaglutide from $183 and tirzepatide from $283, while shared tirzepatide displays show $329. Complete current quotes remain unconfirmed.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.